| Application no. and date | 17892821.4 (espacenet) (Federated) (European Patent Register), 20171017 | | Patent/reg. no. and date | DK/EP 3570816, 20230816 | | Publication date | 20191127 | | Priority no. and date | KR 20170009727, 20170120 | | EP pub. no. and date |
EP 3570816 20191127 | | Effective date | | | Applicant/owner | Daewoong Co., Ltd., 244,Galmachi-ro
Jungwon-gu
Seongnam-si, Gyeonggi-do 13211, KR | | Applicant ref. no. | | | Inventor | YIM, Hyeona, 103-1204
190 Sinheung-ro
Bucheon-si
Gyeonggi-do 14549, KR,
KIM, Cheong-Sei, 1221-903
50 Mokdongdong-ro
Yangcheon-gu
Seoul 08097, KR | | Representative | | | Opponent | | | IPC Class | A61K 38/48 (2006.01) , A61K 47/12 (2006.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , A61K 47/38 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61P 21/00 (2006.01) , A61P 25/02 (2006.01) | | Title | STABLE LIQUID COMPOSITION COMPRISING BOTULINUM TOXIN | | Int. application no. | KR2017011438 | | Int. publication no. | WO2018135722 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
